SCHEMBL1748646

SCHEMBL1748646

C[SiH](C)OC(CBr)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3595969 0.81
SCHEMBL8172810 0.77 TSHR (0.32)
SCHEMBL6855585 0.76
SCHEMBL3178092 0.75
SCHEMBL7444210 0.75
SCHEMBL28551468 0.75
SCHEMBL1250066 0.75
SCHEMBL6813065 0.75
SCHEMBL3642760 0.74
SCHEMBL10811138 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105593224-B Novel quinazolinones as bromodomain inhibitors 恒元生物医药科技(苏州)有限公司 2021-05-25 CN disclosed
EP-3027604-B1 NOVEL QUINAZOLINONES AS BROMODOMAIN INHIBITORS ZENITH EPIGENETICS LTD (CA) 2019-02-20 EP disclosed
US-20180092924-A1 NOVEL QUINAZOLINONES AS BROMODOMAIN INHIBITORS RVX THERAPEUTICS INC. (CA) 2018-04-05 US disclosed
US-9855271-B2 Quinazolinones as bromodomain inhibitors ZENITH EPIGENETICS LTD. (CA) 2018-01-02 US disclosed
US-20160193218-A1 NOVEL QUINAZOLINONES AS BROMODOMAIN INHIBITORS ZENITH EPIGENETICS LTD. (CA) 2016-07-07 US disclosed
EP-2338059-B1 Ligands for aggregated tau molecules WISTA LAB LTD (SG) 2015-04-08 EP disclosed
US-8895313-B2 Ligands for aggregated tau molecules WISTA LABORATORIES LTD. (SG) 2014-11-25 US disclosed
US-8030496-B2 Intermediate compound for synthesis of viridiofungin a derivative CHUGAI SEIYAKI KABUSHIKI KAISHA (JP) 2011-10-04 US disclosed
US-20110171739-A1 LIGANDS FOR AGGREGATED TAU MOLECULES WISTA LABORATORIES LTD. 2011-07-14 US disclosed
EP-2338059-A1 LIGANDS FOR AGGREGATED TAU MOLECULES Wista Laboratories Ltd. (SG) 2011-06-29 EP disclosed
EP-0777666-B1 SUBSTITUTED PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES MERRELL PHARMA INC (US) 1999-03-03 EP disclosed
EP-0777666-A1 NOVEL SUBSTITUTED PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES MERRELL PHARMACEUTICALS INC. (US) 1997-06-11 EP disclosed
EP-0532088-B1 O-Heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroaryl macrolides MERCK & CO INC (US) 1996-12-04 EP disclosed
WO-1996006094-A1 NOVEL SUBSTITUTED PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES MERRELL PHARMACEUTICALS INC. (US) 1996-02-29 WO disclosed
US-5349061-A O-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity MERCK & CO., INC. (US) 1994-09-20 US disclosed
US-5310901-A Autoimmune diseases; antiinflammatory agents; fungicides; prevention of organ transplant rejection; alkylation and/or arylation at C-42 MERCK & CO., INC. (US) 1994-05-10 US disclosed
US-5252732-A D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity MERCK & CO., INC. (US) 1993-10-12 US disclosed
WO-1993005058-A1 O-HETEROARYL, O-ALKYLHETEROARYL, O-ALKENYLHETEROARYL AND O-ALKYNYLHETEROARYLMACROLIDES MERCK & CO., INC. (US) 1993-03-18 WO disclosed
EP-0532088-A1 O-Heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroaryl macrolides MERCK & CO. INC. (US) 1993-03-17 EP disclosed
US-5192758-A Antibiotics MERCK & CO., INC. (US) 1993-03-09 US disclosed